Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent's ability to distribute multiple life-saving opioid overdose ...

GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S ...

Public trust in a federal access program for the overdose drug Naloxone has been shaken after more than a year of shortages ...

To ensure its lifesaving opioid overdose reversal medicine is more accessible, Padagis is lowering the price of its Naloxone Nasal Spray on Amazon ALLEGAN, Mich., Feb. 3, 2025 /PRNewswire ...

Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...

"Meeting the needs of our patients and customers by now offering two nasal naloxone products at different strengths - NARCAN ® Nasal Spray 4 mg and KLOXXADO ® Nasal Spray 8 mg - allows Emergent to do ...

Emergent distributes NARCAN® Nasal Spray 4 mg, which is the first FDA-approved over-the-counter naloxone product for the emergency treatment of opioid overdose. Under the terms of the ...